Elevation Pharmaceuticals
Latest round
- Series B
Last raised
- Dec 2011
Total raised
- $44M
Investors
- 6
About Elevation Pharmaceuticals
Elevation Pharmaceuticals, Inc.Founded in 2008 in San Diego, US, Elevation Pharmaceuticals, Inc. specializes in respiratory therapeutics.Elevation Pharma specializes in the development and commercialization of innovative therapeutic solutions aimed at addressing unmet medical needs in respiratory diseases. Its flagship product, a proprietary inhalation formulation, is designed to improve the delivery and effectiveness of medication for patients suffering from conditions such as asthma and chronic obstructive pulmonary disease (COPD). The formulation utilizes advanced aerosol technology, allowing for more efficient drug absorption and better patient compliance. This product is primarily targeted at hospitals, healthcare providers, and pharmacies, serving a diverse clientele that includes both direct consumers and institutional healthcare settings.The revenue structure of Elevation Pharma revolves around direct sales of its core inhalation products to healthcare providers and pharmacies, alongside potential partnerships with pharmaceutical distributors. Transactions typically occur through B2B channels, where healthcare entities place orders based on patient demand and inventory needs. The pricing strategy for its flagship inhalation formulation is structured to reflect its advanced technology and efficacy, with costs aligned to facilitate accessibility while ensuring profitability. Through established distribution agreements, Elevation Pharma maintains a steady flow of products to various healthcare institutions, enhancing its market reach and operational efficiency.Elevation Pharmaceuticals, Inc. The company is focused on upcoming new products in respiratory therapeutics, although specific launch dates have not been disclosed. Furthermore, Elevation is targeting expansion into new international markets, particularly in Asia and South America, with a strategic timeline for implementation in the next few years. This strategic initiative aims to enhance accessibility to their innovative inhalation solutions globally.
Who invested in Elevation Pharmaceuticals
6 investors across 3 rounds
See all investors in Elevation Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Elevation Pharmaceuticals
Who invested in Elevation Pharmaceuticals?
Elevation Pharmaceuticals has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Elevation Pharmaceuticals raised?
Elevation Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Elevation Pharmaceuticals last raise money?
Elevation Pharmaceuticals's most recent round on record is a Series B, in Dec 2011.
What does Elevation Pharmaceuticals do?
Elevation Pharmaceuticals, Inc.
Where is Elevation Pharmaceuticals headquartered?
Elevation Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like Elevation Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Elevation Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Elevation Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.